Crit Care:ICU幸存者长期结局的决定因素!

2018-01-19 xing.T MedSci原创

由此可见,FROG-ICU研究确定了在ICU出院时潜在的临床和生物学因素,这些因素与ICU出院后的长期不良结局相关,其可以指导出院计划和直接干预。

与一般人群相比,重症监护病房(ICU)幸存者长期生存率降低。近日,危重病医学领域权威杂志Critical Care上发表了一篇研究文章,研究人员旨在明确ICU出院时与长期不良结局相关的参数可能有助于靶向高危人群进行干预。该研究的主要目标是确定ICU出院后一年内死亡相关的临床和生物学决定因素。

FROG-ICU是在ICU幸存者出院后1年内进行的一项前瞻性观察性多中心队列研究,包含了法国和比利时的21个内科、外科或混合ICU。所有连续入住ICU至ICU出院超过24小时的需要有创机械通气和/或血管活性药物支持的患者被纳入研究。该研究的主要结局指标是ICU出院后1年内的全因死亡率。研究人员测定了受试者ICU出院的临床和生物学参数,包括循环心血管生物标志物B型利钠肽前体N末端、高敏肌钙蛋白I、生物活性肾上腺髓质素和可溶性ST2,并使用验证了的剥夺指数(FDep)进行社会经济状况评估。

在1570例出院的ICU幸存者中,其中333例(21%)幸存者死于第二年。多变量分析确定了年龄、合并症、输入红细胞、ICU住院时间和ICU出院时的常见异常临床因素(低收缩压、体温、总蛋白、血小板和白细胞计数)作为独立因素与1年死亡率相关。当加入多变量模型时,升高的心脏和血管衰竭生物标记物与1年死亡风险独立相关,合并死亡风险几乎增加3倍(校正比值比为2.84(95%可信区间为1.73-4.65),P<0.001)。

由此可见,FROG-ICU研究确定了在ICU出院时潜在的临床和生物学因素,这些因素与ICU出院后的长期不良结局相关,其可以指导出院计划和直接干预。

原始出处:


Etienne Gayat,et al. Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study.Critical Care.2018. https://doi.org/10.1186/s13054-017-1922-8

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1671011, encodeId=de9216e10117e, content=<a href='/topic/show?id=bd58310846e' target=_blank style='color:#2F92EE;'>#决定因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31084, encryptionId=bd58310846e, topicName=决定因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7726816052, createdName=wushaoling, createdTime=Tue Jul 17 04:36:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385099, encodeId=01451385099fb, content=<a href='/topic/show?id=99d99e03311' target=_blank style='color:#2F92EE;'>#长期结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97033, encryptionId=99d99e03311, topicName=长期结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Sun Jan 21 06:36:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280316, encodeId=d2f528031611, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Sat Jan 20 10:57:35 CST 2018, time=2018-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280146, encodeId=7dd228014605, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM6P57Bs8gOPaY1cQP9lIia0lmZOEXraGaoicqNToIslXDKw/0, createdBy=7a041951742, createdName=衣带渐宽, createdTime=Fri Jan 19 21:18:07 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1671011, encodeId=de9216e10117e, content=<a href='/topic/show?id=bd58310846e' target=_blank style='color:#2F92EE;'>#决定因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31084, encryptionId=bd58310846e, topicName=决定因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7726816052, createdName=wushaoling, createdTime=Tue Jul 17 04:36:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385099, encodeId=01451385099fb, content=<a href='/topic/show?id=99d99e03311' target=_blank style='color:#2F92EE;'>#长期结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97033, encryptionId=99d99e03311, topicName=长期结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Sun Jan 21 06:36:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280316, encodeId=d2f528031611, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Sat Jan 20 10:57:35 CST 2018, time=2018-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280146, encodeId=7dd228014605, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM6P57Bs8gOPaY1cQP9lIia0lmZOEXraGaoicqNToIslXDKw/0, createdBy=7a041951742, createdName=衣带渐宽, createdTime=Fri Jan 19 21:18:07 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1671011, encodeId=de9216e10117e, content=<a href='/topic/show?id=bd58310846e' target=_blank style='color:#2F92EE;'>#决定因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31084, encryptionId=bd58310846e, topicName=决定因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7726816052, createdName=wushaoling, createdTime=Tue Jul 17 04:36:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385099, encodeId=01451385099fb, content=<a href='/topic/show?id=99d99e03311' target=_blank style='color:#2F92EE;'>#长期结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97033, encryptionId=99d99e03311, topicName=长期结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Sun Jan 21 06:36:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280316, encodeId=d2f528031611, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Sat Jan 20 10:57:35 CST 2018, time=2018-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280146, encodeId=7dd228014605, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM6P57Bs8gOPaY1cQP9lIia0lmZOEXraGaoicqNToIslXDKw/0, createdBy=7a041951742, createdName=衣带渐宽, createdTime=Fri Jan 19 21:18:07 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-01-20 Jackie Li

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1671011, encodeId=de9216e10117e, content=<a href='/topic/show?id=bd58310846e' target=_blank style='color:#2F92EE;'>#决定因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31084, encryptionId=bd58310846e, topicName=决定因素)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e7726816052, createdName=wushaoling, createdTime=Tue Jul 17 04:36:00 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385099, encodeId=01451385099fb, content=<a href='/topic/show?id=99d99e03311' target=_blank style='color:#2F92EE;'>#长期结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97033, encryptionId=99d99e03311, topicName=长期结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c31495, createdName=liuyg0228, createdTime=Sun Jan 21 06:36:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280316, encodeId=d2f528031611, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfBfgWn9nXBgH1sNSiaOAKhsKpN40jDHQKqcRzovau5VibLvREN8uxnu9sKoScBicHSiaDMmbveibFdrBiaD4k4IOPwlG/0, createdBy=b5d11730951, createdName=Jackie Li, createdTime=Sat Jan 20 10:57:35 CST 2018, time=2018-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=280146, encodeId=7dd228014605, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/Q3auHgzwzM6P57Bs8gOPaY1cQP9lIia0lmZOEXraGaoicqNToIslXDKw/0, createdBy=7a041951742, createdName=衣带渐宽, createdTime=Fri Jan 19 21:18:07 CST 2018, time=2018-01-19, status=1, ipAttribution=)]
    2018-01-19 衣带渐宽

    学习

    0

相关资讯

Medicine:ICU挥发性镇静系统回顾和荟萃分析

与静脉(IV)镇静相比,重症监护室(ICU)中的挥发性镇静可减少不良事件的发生次数并改善患者预后。我们进行了系统回顾和荟萃分析,比较ICU成人患者中挥发性和静脉镇静的影响。

Ann Intensive Care:入住ICU前使用二甲双胍能否降低院内死亡率?

2017年12月,发表在《Ann Intensive Care》上的一项回顾性队列研究,在ICU住院的糖尿病患者中,对入住ICU前使用二甲双胍的影响进行了考察。

Crit Care:ICU中AKI患者开始肾脏替代治疗的时机和慢性肾脏病的长期风险如何?

由此可见,早期接受RRT治疗与90天死亡率增加有关。在存活了90天的患者中,早期接受治疗与长期死亡率或CKD和ESRD风险无关。尽管观察设计可能导致潜在的混杂因素,但该研究的结果并不支持早期RRT治疗优于晚期RRT。

关于ICU镇静的十项建议

在严重疾病和接受各种生命支持技术的重症患者治疗中,关注疼痛、焦虑、痛苦、失眠十分重要,且充满挑战。理想状态下,患者能够表达他们的症状和严重程度,医生基于症状给予合理的药物或非药物治疗。本文提出重症患者镇静治疗的十项建议,以改善患者舒适度,避免过度镇静。

Crit care med:脓毒性性心肌病知多少!

近期,一篇发表在杂志Crit care med上的文章重点描述了在成人ICU中,脓毒性心肌病的病理生理、疾病管理以及影响的临床应用。研究者们对相关文章进行了PubMed文献综述。只有研究人类脓毒症的英文文章被列入综述内容。脓毒性心肌病的多种竞争性定义阻碍了对该疾病的理解。尽管许多脓毒症患者发生了心脏功能障碍,但是,脓毒性心肌病对预后和治疗的影响仍有待进一步的证实。脓毒性心肌病的治疗目的在于治疗潜在

Lancet respir med:诱导低体温是否可降低脓毒性休克患者的死亡率?

重度感染的动物模型显示诱导低体温24小时可提高循环和呼吸系统功能并减少死亡。现研究人员进行研究,探究将核心体温降至32-34℃是否可减少呼吸机依赖性的脓毒性休克患者的器官功能异常和死亡。研究人员开展一随机、对照、非盲的临床试验,从欧洲和北美的三个国家的10个重症监护室招募重度脓毒症或脓毒性休克患者,且要求平均动脉压低于70mmHg、在ICU病房依赖呼吸机、50岁以上、预测在ICU监护超过24小时,